- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1746-1596
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The predictive significance of CD20 expression in B-cell lymphomas ; volume:6 ; number:1 ; day:12 ; month:4 ; year:2011 ; pages:1-6 ; date:12.2011
Diagnostic pathology ; 6, Heft 1 (12.4.2011), 1-6, 12.2011
- Creator
-
Prevodnik, Veronika Kloboves
- Contributor
-
Lavrenčak, Jaka
Horvat, Mateja
Novakovič, Barbara Jezeršek
SpringerLink (Online service)
- DOI
-
10.1186/1746-1596-6-33
- URN
-
urn:nbn:de:1111-2016080739089
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Prevodnik, Veronika Kloboves
- Lavrenčak, Jaka
- Horvat, Mateja
- Novakovič, Barbara Jezeršek
- SpringerLink (Online service)
Other Objects (12)
Diagnosis and treatment of CD20 negative B cell lymphomas
Bioinformatical analysis of B-cell lymphomas
TOX expression in cutaneous B-cell lymphomas
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
Tumor Evolution through Differentiation in B-Cell Lymphomas
Epigenetic-mediated apoptosis in aggressive B-cell lymphomas
Cytokine expression in B-cell non-Hodgkin lymphomas
Obinutuzumab (GA101) for the Treatment of Chronic Lymphocytic Leukemia and Other B-Cell Non-Hodgkin's Lymphomas: A Glycoengineered Type II CD20 Antibody
Clinical characteristics and prognostic factors of bone lymphomas: focus on the clinical significance of multifocal bone involvement by primary bone large B-cell lymphomas
Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders
Aggressive B‐cell lymphomas with a primary bone marrow presentation
COVID-19 in patients receiving CD20-depleting immunochemotherapy for B-cell lymphoma
Diagnosis and treatment of CD20 negative B cell lymphomas
Bioinformatical analysis of B-cell lymphomas
TOX expression in cutaneous B-cell lymphomas
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
Tumor Evolution through Differentiation in B-Cell Lymphomas
Epigenetic-mediated apoptosis in aggressive B-cell lymphomas
Cytokine expression in B-cell non-Hodgkin lymphomas
Obinutuzumab (GA101) for the Treatment of Chronic Lymphocytic Leukemia and Other B-Cell Non-Hodgkin's Lymphomas: A Glycoengineered Type II CD20 Antibody
Clinical characteristics and prognostic factors of bone lymphomas: focus on the clinical significance of multifocal bone involvement by primary bone large B-cell lymphomas
Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders
Aggressive B‐cell lymphomas with a primary bone marrow presentation
COVID-19 in patients receiving CD20-depleting immunochemotherapy for B-cell lymphoma
Diagnosis and treatment of CD20 negative B cell lymphomas
Bioinformatical analysis of B-cell lymphomas
TOX expression in cutaneous B-cell lymphomas
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
Tumor Evolution through Differentiation in B-Cell Lymphomas
Epigenetic-mediated apoptosis in aggressive B-cell lymphomas
Cytokine expression in B-cell non-Hodgkin lymphomas
Obinutuzumab (GA101) for the Treatment of Chronic Lymphocytic Leukemia and Other B-Cell Non-Hodgkin's Lymphomas: A Glycoengineered Type II CD20 Antibody
Clinical characteristics and prognostic factors of bone lymphomas: focus on the clinical significance of multifocal bone involvement by primary bone large B-cell lymphomas
Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders
Aggressive B‐cell lymphomas with a primary bone marrow presentation